Skip to Main Content

Paper Details

Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination.
NPJ Breast Cancer
8
2021
Author NameAffiliation
Pier SelenicaMemorial Sloan Kettering Cancer Center
Pier SelenicaUniversity of Maastricht
David N BrownMemorial Sloan Kettering Cancer Center
Liying ZhangMemorial Sloan Kettering Cancer Center
Simon N PowellMemorial Sloan Kettering Cancer Center
Simon N PowellSloan Kettering Institute
Britta WeigeltMemorial Sloan Kettering Cancer Center
Nadeem RiazMemorial Sloan Kettering Cancer Center
Jorge S Reis-FilhoMemorial Sloan Kettering Cancer Center
  • 1 - 9

Datasets

Release 1.2